1. Home
  2. AGPU vs PYPD Comparison

AGPU vs PYPD Comparison

Compare AGPU & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Axe Compute Inc. Common Stock

AGPU

Axe Compute Inc. Common Stock

HOLD

Current Price

$8.58

Market Cap

83.5M

Sector

N/A

ML Signal

HOLD

Logo PolyPid Ltd.

PYPD

PolyPid Ltd.

HOLD

Current Price

$4.35

Market Cap

71.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AGPU
PYPD
Founded
2002
2008
Country
United States
Israel
Employees
14
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
83.5M
71.7M
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
AGPU
PYPD
Price
$8.58
$4.35
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$12.25
AVG Volume (30 Days)
508.1K
325.1K
Earning Date
05-14-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$12,476.23
N/A
Revenue Next Year
$55.17
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.03
$3.06
52 Week High
$10.86
$5.73

Technical Indicators

Market Signals
Indicator
AGPU
PYPD
Relative Strength Index (RSI) 48.49 41.98
Support Level $6.26 $4.06
Resistance Level $8.82 $4.44
Average True Range (ATR) 1.00 0.43
MACD -0.07 -0.14
Stochastic Oscillator 12.00 20.67

Price Performance

Historical Comparison
AGPU
PYPD

About AGPU Axe Compute Inc. Common Stock

Axe Compute Inc functions as an active infrastructure operator. The company intends to expand access to AI compute resources by utilizing the Aethir network, which provides scalable, cost-efficient cloud GPU services for AI, machine learning, gaming, and rendering applications. Through the use of Aethir's decentralized international infrastructure, the company aims to provide access to bare-metal GPUs at scale for both emerging and established organizations.

About PYPD PolyPid Ltd.

PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. The company's product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.

Share on Social Networks: